On Feb. 27, reporters Kelly Grant and Chris Hannay answered reader questions on the rise of Ozempic and similar drugs in Canada, what experts are saying about the health risks and benefits and how it ...

Last year, the U.S. Senate Special Committee on Aging launched a bipartisan effort to expose the public health and national security risks America’s overreliance on foreign-made generic drugs poses to ...

— Adrian García, CEO of Saya Bio. MEXICO CITY, MEXICO, January 26, 2026 /EINPresswire.com/ — Saya Biologics (Saya Bio), a Mexican biopharmaceutical company ...

Oklahomans who purchased certain generic prescription drugs between 2009 and 2019 may be eligible for compensation after two pharmaceutical companies agreed to pay $17.85 million to settle allegations ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Senators introduced legislation on Thursday that would ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Emory is the data editor at ...

New Jersey has joined 42 other states in suing global pharmaceutical company Novartis and its spin-off Sandoz for engaging in what they describe as “one of the most egregious examples of ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company plans to use an ...

This weight-loss leader was drubbed last year. It's a popular pick as a 2026 rebound candidate. More than that popularity, it has credible catalysts to bounce back this year. Fast-forward to 2026, and ...

“Congress… evidently viewed that prospect [of off-label, patented uses] as an acceptable cost of expedited competition with respect to lawful unpatented uses.” – U.S. Solicitor General On Friday, the ...